These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19429055)
1. Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome. Liu ZH; Smith CB Neurosci Lett; 2009 Apr; 454(1):62-6. PubMed ID: 19429055 [TBL] [Abstract][Full Text] [Related]
2. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388 [TBL] [Abstract][Full Text] [Related]
3. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. Mines MA; Yuskaitis CJ; King MK; Beurel E; Jope RS PLoS One; 2010 Mar; 5(3):e9706. PubMed ID: 20300527 [TBL] [Abstract][Full Text] [Related]
4. Deletion of Nolan SO; Reynolds CD; Smith GD; Holley AJ; Escobar B; Chandler MA; Volquardsen M; Jefferson T; Pandian A; Smith T; Huebschman J; Lugo JN Brain Behav; 2017 Oct; 7(10):e00800. PubMed ID: 29075560 [TBL] [Abstract][Full Text] [Related]
5. Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. McNaughton CH; Moon J; Strawderman MS; Maclean KN; Evans J; Strupp BJ Behav Neurosci; 2008 Apr; 122(2):293-300. PubMed ID: 18410169 [TBL] [Abstract][Full Text] [Related]
6. Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse. Sørensen EM; Bertelsen F; Weikop P; Skovborg MM; Banke T; Drasbek KR; Scheel-Krüger J Behav Pharmacol; 2015 Dec; 26(8 Spec No):733-40. PubMed ID: 26110222 [TBL] [Abstract][Full Text] [Related]
8. Altered anxiety and social behaviors in a mouse model of Fragile X syndrome treated with hyperbaric oxygen therapy. Luo CW; Deng XY; Cheng JL; Xiao DX; Zhang CY; Feng JX; Chen SQ; Hu N J Clin Neurosci; 2020 Mar; 73():245-251. PubMed ID: 32067828 [TBL] [Abstract][Full Text] [Related]
9. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism. Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743 [TBL] [Abstract][Full Text] [Related]
10. Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008). Brodkin ES Behav Neurosci; 2008 Apr; 122(2):483-9. PubMed ID: 18410188 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome. Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086 [TBL] [Abstract][Full Text] [Related]
12. A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis. Qin M; Entezam A; Usdin K; Huang T; Liu ZH; Hoffman GE; Smith CB Neurobiol Dis; 2011 Apr; 42(1):85-98. PubMed ID: 21220020 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome. Rosenheck M; Sheeler C; Saré RM; Gurney ME; Smith CB Neurobiol Dis; 2021 Nov; 159():105485. PubMed ID: 34411704 [TBL] [Abstract][Full Text] [Related]
14. Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle. Saré RM; Levine M; Smith CB eNeuro; 2016; 3(2):. PubMed ID: 27294193 [TBL] [Abstract][Full Text] [Related]
15. The same stress elicits different effects on anxiety-like behavior in rat models of Fmr1 Dey R; Chattarji S Behav Brain Res; 2022 Jun; 428():113892. PubMed ID: 35436530 [TBL] [Abstract][Full Text] [Related]
16. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Sinclair D; Featherstone R; Naschek M; Nam J; Du A; Wright S; Pance K; Melnychenko O; Weger R; Akuzawa S; Matsumoto M; Siegel SJ eNeuro; 2017; 4(1):. PubMed ID: 28451631 [TBL] [Abstract][Full Text] [Related]
17. Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice. Gantois I; Pop AS; de Esch CE; Buijsen RA; Pooters T; Gomez-Mancilla B; Gasparini F; Oostra BA; D'Hooge R; Willemsen R Behav Brain Res; 2013 Feb; 239():72-9. PubMed ID: 23142366 [TBL] [Abstract][Full Text] [Related]
18. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Spencer CM; Alekseyenko O; Hamilton SM; Thomas AM; Serysheva E; Yuva-Paylor LA; Paylor R Autism Res; 2011 Feb; 4(1):40-56. PubMed ID: 21268289 [TBL] [Abstract][Full Text] [Related]